The Potential Future Impact of CAR T Cell Therapy in Adult ALL

Experts in hematology oncology consider unmet needs for adult patients with relapsed/refractory ALL and reflect on the potential impact that FDA approval of CAR T cell therapy would have on the treatment landscape.

Related Videos
Jorge E. Cortes, MD
Bradley W. Christensen, MD
Expert on AML
Expert on AML
Craig Sauter, MD
Experts on AML
Expert on AML
Experts on MDS
Expert on MDS
Expert on AML
Related Content